PT Metro Healthcare Indonesia Tbk

Jakarta Stock Exchange CARE.JK

PT Metro Healthcare Indonesia Tbk EBITDA for the year ending December 31, 2023: USD -499.21 K

PT Metro Healthcare Indonesia Tbk EBITDA is USD -499.21 K for the year ending December 31, 2023, a -139.58% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

PT Metro Healthcare Indonesia Tbk EBITDA for the year ending December 31, 2022 was USD 1.26 M, a -42.61% change year over year.
PT Metro Healthcare Indonesia Tbk EBITDA for the year ending December 31, 2021 was USD 2.20 M, a -15.64% change year over year.
PT Metro Healthcare Indonesia Tbk EBITDA for the year ending December 31, 2020 was USD 2.61 M, a 520.06% change year over year.
PT Metro Healthcare Indonesia Tbk EBITDA for the year ending December 31, 2019 was USD 420.16 K, a 44.72% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Jakarta Stock Exchange: CARE.JK

PT Metro Healthcare Indonesia Tbk

CEO	Engineer Henry Kembaren M.M.
IPO Date	March 13, 2020
Location	Indonesia
Headquarters	Jl. Raya Serang Km 16,8
Employees	802
Sector	Health Care
Industries Hospitals & Clinics

Description

PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. It owns and operates 7 hospitals. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Anugrah Kasih Rajawali.

Key trends

Past 5 years